title: Re: Neuroleptic malignant syndrome associated with quetiapine.
authors.forename: J
authors.initials: J
authors.lastname: Karagianis
authors.forename: L
authors.initials: L
authors.lastname: Phillips
authors.forename: K
authors.initials: K
authors.lastname: Hogan
authors.forename: K
authors.initials: K
authors.lastname: LeDrew
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003987:Dibenzothiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008152:Loxapine / Q000009:adverse effects / Q000627:therapeutic use; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D000069348:Quetiapine Fumarate; D012307:Risk Factors
chemical_list: D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate; D008152:Loxapine